Overview

Investigation of the Safety and Efficacy of Eszopiclone in Insomnia Patients

Status:
Completed
Trial end date:
2015-12-22
Target enrollment:
Participant gender:
Summary
To investigate the safety and efficacy of administration of eszopiclone for 4 weeks in insomnia patients.
Details
Lead Sponsor:
Eisai Co., Ltd.
Treatments:
Eszopiclone